| Size | Price | Stock |
|---|---|---|
| 5mg | $52 | In-stock |
| 10mg | $84 | In-stock |
| 25mg | $170 | In-stock |
| 50mg | $288 | In-stock |
| 100mg | $480 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-18775 |
| M.Wt: | 373.36 |
| Formula: | C17H19N5O5 |
| Purity: | >98 % |
| Solubility: | DMSO : ≥ 100 mg/mL;H2O : < 0.1 mg/mL (ultrasonic) |
N6-(4-Hydroxybenzyl) adenosine (Para-topolin riboside) is an equilibrative nucleoside transporter 1 (ENT1) inhibitor and a selective agonist of adenosine A2a receptor (A2aR), and also exhibits activity against P2Y12 receptor. N6-(4-Hydroxybenzyl) adenosine reduces ethanol intake and preference, attenuates operant conditioning-induced ethanol place preference, decreases the value of ethanol-related rewards, and inhibits collagen-induced platelet aggregation. N6-(4-Hydroxybenzyl) adenosine can be used in studies related to alcohol use disorder[1][2].
In Vitro:N6-(4-Hydroxybenzyl)adenosine potently inhibits collagen-induced aggregation of washed human platelets with an IC50 of 6.77 μM[2].
In Vivo:N6-(4-Hydroxybenzyl)adenosine (0.1 mg/kg; i.p.; single dose) dampens ethanol preference and consumption in high ethanol drinking male C57BL/6J mice without changing total liquid intake[1].
N6-(4-Hydroxybenzyl)adenosine (0.1 mg/kg; i.p.; single dose) dampens operant conditioning-induced ethanol zone preference in food-restricted male C57BL/6J mice without altering locomotion[1].
N6-(4-Hydroxybenzyl)adenosine (0.1 mg/kg; i.p.; single dose) reduces the value of ethanol-containing reward in food-restricted male C57BL/6J mice, eliminating reward devaluation-induced differences in nose-poking behavior[1].
N6-(4-Hydroxybenzyl)adenosine (0.1 mg/kg; i.p.; single dose) decreases the value of ethanol-only reward in food-restricted male C57BL/6J mice, eliminating reward devaluation-induced differences in nose-poking behavior[1].
N6-(4-Hydroxybenzyl)adenosine (0.03-0.3 mg/kg; i.p.; single dose) at doses up to 0.1 mg/kg does not alter locomotor activity in male C57BL/6J mice, while 0.3 mg/kg reduces locomotion[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.